[1] WITKE W,SUTHERLAND J D,SHARPE A,et al.Profilin I is essential for cell survival and cell division in early mouse development[J]. Proc Natl Acad Sci U S A,2001,98(7):3832-3836. [2] BIRBACH A.Profilin,a multi-modal regulator of neuronal plasticity[J]. Bioessays,2008,30(10):994-1002. [3] CARLSSON L,NYSTROM L E,SUNDKVIST I,et al.Actin polymerizability is influenced by profilin,a low molecular weight protein in non-muscle cells[J]. J Mol Biol,1977,115(3):465-483. [4] WITTENMAYER N,JANDRIG B,ROTHKEGEL M,et al.Tumor suppressor activity of profilin requires a functional actin binding site[J]. Mol Biol Cell,2004,15(4):1600-1608. [5] METZLER W J,FARMER B N,CONSTANTINE K L,et al.Refined solution structure of human profilin I[J]. Protein Sci,1995,4(3):450-459. [6] REINHARD M,GIEHL K,ABEL K,et al.The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins[J]. EMBO J,1995,14(8):1583-1589. [7] BARZIK M,KOTOVA T I,HIGGS H N,et al.Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins[J]. J Biol Chem,2005,280(31):28653-28662. [8] WITKE W.The role of profilin complexes in cell motility and other cellular processes[J]. Trends Cell Biol,2004,14(8):461-469. [9] HENDERSON C A,GOMEZ C G,NOVAK S M,et al.Overview of the muscle cytoskeleton[J]. Compr Physiol,2017,7(3):891-944. [10] YARMOLA E G,BUBB M R.How depolymerization can promote polymerization:The case of actin and profilin[J]. Bioessays,2009,31(11):1150-1160. [11] KOVAR D R,HARRIS E S,MAHAFFY R,et al.Control of the assembly of ATP-and ADP-actin by formins and profilin[J]. Cell,2006,124(2):423-435. [12] MAHONEY N M,JANMEY P A,ALMO S C.Structure of the profilin-poly-L-proline complex involved in morphogenesis and cytoskeletal regulation[J]. Nat Struct Biol,1997,4(11):953-960. [13] YANG C,HUANG M,DEBIASIO J,et al.Profilin enhances Cdc42-induced nucleation of actin polymerization[J]. J Cell Biol,2000,150(5):1001-1012. [14] ROTTY J D,WU C,HAYNES E M,et al.Profilin-1 serves as a gatekeeper for actin assembly by Arp2/3-dependent and -independent pathways[J]. Dev Cell,2015,32(1):54-67. [15] SUAREZ C,CARROLL R T,BURKE T A,et al.Profilin regulates F-actin network homeostasis by favoring formin over Arp2/3 complex[J]. Dev Cell,2015,32(1):43-53. [16] DA S J,DOTTI C G.Breaking the neuronal sphere:Regulation of the actin cytoskeleton in neuritogenesis[J]. Nat Rev Neurosci,2002,3(9):694-704. [17] LAMBRECHTS A,JONCKHEERE V,PELEMAN C,et al.Profilin- I-ligand interactions influence various aspects of neuronal differentiation[J]. J Cell Sci,2006,119(8):1570-1578. [18] DING Z,BAE Y H,ROY P.Molecular insights on conte- xtspecific role of profilin-1 in cell migration[J]. Cell Adh Migr,2012,6(5):442-449. [19] YAO W,JI S,QIN Y,et al.Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1alpha axis[J]. Mol Cancer,2014,13:187. [20] ZOU L,DING Z,ROY P.Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation[J]. J Cell Physiol,2010,223(3):623-629. [21] WU N,ZHANG W,YANG Y,et al.Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration[J]. Proteomics,2006,6(22):6095-6106. [22] SHEN K,XI Z,XIE J,et al.Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1[J]. Oncotarget, 2016,7(35):56650-56663. [23] WANG Z,SHI Z,ZHANG L,et al.Profilin 1,negatively regulated by microRNA-19a-3p,serves as a tumor suppressor in human hepatocellular carcinoma[J]. Pathol Res Pract,2019,215(3):499-505. [24] JANKE J,SCHLUTER K,JANDRIG B,et al.Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1[J]. J Exp Med,2000,191(10):1675-1686. [25] ZOU L,JARAMILLO M,WHALEY D,et al.Profilin-1 is a negative regulator of mammary carcinoma aggressiveness[J]. Br J Cancer,2007,97(10):1361-1371. [26] DING Z,LAMBRECHTS A,PAREPALLY M,et al.Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis[J]. J Cell Sci,2006,119(19):4127-4137. [27] FAN Y,ARIF A,GONG Y,et al.Stimulus-dependent phosphorylation of profilin-1 in angiogenesis[J]. Nat Cell Biol,2012,14(10):1046-1056. [28] DAS T,BAE Y H,WELLS A,et al.Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells[J]. J Cell Physiol,2009,218(2):436-443. [29] KANAUJIYA J K,LOCHAB S,KAPOOR I,et al.Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells[J]. Proteomics,2013,13(14):2100-2112. [30] MINAMIDA S,IWAMURA M,KODERA Y,et al.Profilin 1 overexpression in renal cell carcinoma[J]. Int J Urol,2011,18(1):63-71. [31] WANG Y,ZHANG J,GAO H,et al.Profilin-1 promotes the development of hypertension-induced artery remodeling[J]. J Histochem Cytochem,2014,62(4):298-310. [32] MOUSTAFA-BAYOUMI M,ALHAJ M A,EL-SAYED O,et al.Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1[J]. J Biol Chem,2007,282(52):37632-37639. [33] HASSONA M D,ABOUELNAGA Z A,ELNAKISH M T,et al.Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries[J]. Am J Physiol Heart Circ Physiol,2010,298(6):H2112-H2120. [34] 牛欢欢,钟久昌. 前纤维蛋白1与心血管疾病关系研究的进展[J]. 心血管康复医学杂志,2010,19(2):220-223. [35] WOODWARD M.Use of national data sources in diabetes epidemiology[J]. Lancet Diabetes Endocrinol,2015,3(2):92-93. [36] HAMILTON S J,WATTS G F.Endothelial dysfunction in diabetes:Pathogenesis,significance,and treatment[J]. Rev Diabet Stud,2013,10(2):133-156. [37] PITOCCO D,ZACCARDI F,DI S E,et al.Oxidative stress,nitric oxide,and diabetes[J]. Rev Diabet Stud,2010,7(1):15-25. [38] ZHAO D,YANG J,YANG L.Insights for oxidative stress and mTOR signaling in myocardial ischemia/reperfusion injury under diabetes[J]. Oxid Med Cell Longev,2017,2017:6437467. [39] NAWROCKA D,KORNICKA K,SZYDLARSKA J,et al.Basic fibroblast growth factor inhibits apoptosis and promotes proliferation of adipose-derived mesenchymal stromal cells isolated from patients with type 2 diabetes by reducing cellular oxidative stress[J]. Oxid Med Cell Longev,2017,2017:3027109. [40] ROMEO G,FRANGIONI J V,KAZLAUSKAS A.Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction[J]. FASEB J,2004,18(6):725-727. [41] ROMEO G R,MOULTON K S,KAZLAUSKAS A.Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse[J]. Circ Res,2007,101(4):357-367. [42] LI Z,ZHONG Q,YANG T,et al.The role of profilin-1 in endothelial cell injury induced by advanced glycation end products(AGEs)[J]. Cardiovasc Diabetol,2013,12:141. [43] SREEDHARAN J,BROWN R J.Amyotrophic lateral sclerosis:Problems and prospects[J]. Ann Neurol,2013,74(3):309-316. [44] 卢义晨. 前纤维蛋白1在多发性骨髓瘤中通过促进自噬参与细胞耐药的研究[D]. 长春:吉林大学,2018. [45] RENTON A E,CHIO A,TRAYNOR B J.State of play in amyotrophic lateral sclerosis genetics[J]. Nat Neurosci,2014,17(1):17-23. [46] IIDA A,HOSONO N,SANO M,et al.Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese[J]. Neurobiol Aging,2012,33(8):1819-1843. [47] SMITH B N,TICOZZI N,FALLINI C,et al.Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS[J]. Neuron,2014,84(2):324-331. [48] SMITH B N,VANCE C,SCOTTER E L,et al.Novel mutations support a role for Profilin 1 in the pathogenesis of ALS[J]. Neurobiol Aging,2015,36(3):1602-1617. [49] INGRE C,LANDERS J E,RIZIK N,et al.A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US,Nordic,and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts[J]. Neurobiol Aging,2013,34(6):1701-1708. [50] WU C H,FALLINI C,TICOZZI N,et al.Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis[J]. Nature,2012,488(7412):499-503. [51] ALKAM D,FELDMAN E Z,SINGH A,et al.Profilin1 biology and its mutation,actin(g)in disease[J]. Cell Mol Life Sci,2017,74(6):967-981. [52] FREISCHMIDT A,SCHOPFLIN M,FEILER M S,et al.Profilin 1 with the amyotrophic lateral sclerosis associated mutation T109M displays unaltered actin binding and does not affect the actin cytoskeleton[J]. BMC Neurosci,2015,16:77. [53] DEL P E,BEMPORAD F,TATINI F,et al.Mutations of profilin-1 associated with amyotrophic lateral sclerosis promote aggregation due to structural changes of its native state[J]. ACS Chem Biol,2015,10(11):2553-2563. [54] DEL P E,GORI L,CHITI F.Biophysical analysis of three novel profilin-1 variants associated with amyotrophic lateral sclerosis indicates a correlation between their aggregation propensity and the structural features of their globular state[J]. Biol Chem,2016,397(9):927-937. |